Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-27,917
Closed -$472K 674
2022
Q2
$472K Buy
27,917
+6,529
+31% +$123K 0.02% 320
2022
Q1
$419K Sell
21,388
-3,756
-15% -$65.8K 0.01% 327
2021
Q4
$341K Buy
+25,144
New +$345K 0.01% 227
2020
Q3
Sell
-370
Closed -$5K 624
2020
Q2
$5K Buy
+370
New +$4.55K ﹤0.01% 733
2019
Q3
Sell
-181
Closed -$4K 792
2019
Q2
$4K Buy
+181
New +$4.37K ﹤0.01% 554
2018
Q4
Sell
-144
Closed -$6K 460
2018
Q3
$6K Buy
+144
New +$6.44K ﹤0.01% 305
2018
Q1
Sell
-2,391
Closed -$86K 369
2017
Q4
$86K Hold
2,391
0.01% 208
2017
Q3
$85K Buy
2,391
+942
+65% +$30.8K 0.01% 201
2017
Q2
$48K Hold
1,449
﹤0.01% 250
2017
Q1
$58K Hold
1,449
0.01% 212
2016
Q4
$54K Hold
1,449
0.01% 201
2016
Q3
$53K Buy
+1,449
New +$48.7K 0.01% 165
2015
Q4
Sell
-2,790
Closed -$105K 456
2015
Q3
$105K Hold
2,790
0.02% 95
2015
Q2
$135K Sell
2,790
-840
-23% -$43.2K 0.02% 76
2015
Q1
$181K Buy
+3,630
New +$197K 0.03% 55

Other funds holding NOV

Balentine LLC's NOV Position: Q3 2022 in Review

Balentine LLC sold out of NOV (NOV) in Q3 2022, closing a stake of 27,917 shares — an estimated $472K sold.

Balentine LLC first reported a position in NOV in Q1 2015 and held it in 15 quarters. The position peaked at $472K in Q2 2022. 343 funds tracked by Wall St. Rank hold NOV as of Q3 2022.

  • Balentine LLC reported no remaining NOV position as of Q3 2022 after selling out during the quarter.
  • Balentine LLC sold 27,917 NOV shares in Q3 2022, an estimated $472K.
  • Balentine LLC first reported a position in NOV in Q1 2015 and held it in 15 quarters.
  • Balentine LLC's NOV position peaked at $472K in Q2 2022.
  • 343 funds tracked by Wall St. Rank held NOV as of Q3 2022.

Based on Balentine LLC's 13F filing for Q3 2022, filed 26 Oct 2022.